Emodin suppresses the migration and invasion of melanoma cells.

Emodin(1,3,8-trihydroxy-6-methylanthraquinone), as an active ingredient in rhubarb roots and rhizomes, has been reported to possess various pharmacological properties including anti-tumor effects. Recent studies have confirmed that emodin inhibited cell proliferation and induced apoptosis of cancer cells. However, the inhibitory effect of emodin on the migration and invasion of melanoma cells and its underlying mechanism are still unclear. In the study, we observed the impercipient effects of emodin in B16F10 and A375 melanoma cells with strong metastatic abilities, focusing on the functions and mechanisms of migration and invasion of B16F10 and A375 melanoma cells. CCK-8，colony formation test and Annexin V-FITC / PI staining tests confirmed that emodin possessed anti-proliferative and pro-apoptotic activities in B16F10 and A375 cells. The inhibitory effects on the migration and invasion of B16F10 and A375 cells were proved by wound healing assay and Transwell methods. Moreover, immunofluorescence array approved the decrease in protein expression of MMP-2/-9 by emodin, and western blot analyses revealed that emodin could increase the Bax/Bcl-2 radio and inhibit the MMP-2/-9 protein expression and Wnt/β-catenin pathway in a dose-depended manner. BML-284, as an agonist of Wnt/β-catenin signaling pathway, reversed the effects of emodin on cell growth, migration and invasion in B16F10 cells. These findings may suggest that emodin treatment can be a promising therapeutic strategy for melanoma with highly metastatic abilities.

[1]  Fang Yan,et al.  Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells. , 2020, Biological & pharmaceutical bulletin.

[2]  Jiying Lu,et al.  Theophylline enhances melanogenesis in B16F10 murine melanoma cells through the activation of the MEK 1/2, and Wnt/β-catenin signaling pathways. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  Yuzhen Wang,et al.  Anticancer activity of emodin is associated with downregulation of CD155. , 2019, International immunopharmacology.

[4]  A. Kakizuka,et al.  Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve , 2019, Genes to cells : devoted to molecular & cellular mechanisms.

[5]  Shailesh Singh,et al.  Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways , 2019, Cancer Cell International.

[6]  Xuehua Jiang,et al.  Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial–Mesenchymal Transition via the Wnt/β-Catenin Pathway , 2019, Oncology research.

[7]  Lei Chen,et al.  Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma , 2017, Molecular and Cellular Biochemistry.

[8]  Yuxia Lin,et al.  The biological effect and mechanism of the Wnt/β-catenin signaling pathway on malignant melanoma A375 cells. , 2018, Experimental and therapeutic medicine.

[9]  M. Rath,et al.  Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells. , 2017, Oncology reports.

[10]  Qingxin Cao,et al.  Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo. , 2016, Oncology reports.

[11]  Johnny Lo,et al.  Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma , 2015, Oncotarget.

[12]  Yiguang Jin,et al.  Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  H. Rupasinghe,et al.  A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer , 2015, Phytotherapy research : PTR.

[14]  Hong Shi,et al.  Inhibition of tumor growth by &bgr;-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model , 2015, Melanoma research.

[15]  Saïd C Azoury,et al.  Epidemiology, risk factors, prevention, and early detection of melanoma. , 2014, The Surgical clinics of North America.

[16]  J. Lee,et al.  Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway. , 2014, Oncology reports.

[17]  Pu-wei Yuan,et al.  Emodin enhances osteogenesis and inhibits adipogenesis , 2014, BMC Complementary and Alternative Medicine.

[18]  C. Bertolotto.  Melanoma: From Melanocyte to Genetic Alterations and Clinical Options , 2013, Scientifica.

[19]  R. Schwartz,et al.  Chemoprevention of skin melanoma: facts and myths , 2013, Melanoma research.

[20]  Chih-Yang Huang,et al.  Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition , 2013, Evidence-based complementary and alternative medicine : eCAM.

[21]  M. Li‐Weber,et al.  Targeting apoptosis pathways in cancer by Chinese medicine. , 2013, Cancer letters.

[22]  Shun-Fa Yang,et al.  Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[23]  Weimin Wang,et al.  Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells , 2012, Pharmacological reports : PR.

[24]  Konrad Basler,et al.  The many faces and functions of β‐catenin , 2012, The EMBO journal.

[25]  P. Bu,et al.  Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line. , 2012, Experimental and therapeutic medicine.

[26]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[27]  M. Kahn,et al.  Neutrophil transmigration triggers repair of the lung epithelium via β-catenin signaling , 2011, Proceedings of the National Academy of Sciences.

[28]  Soo-Jin Jeong,et al.  Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes. , 2011, Biological & pharmaceutical bulletin.

[29]  Jinyan Xie,et al.  Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons , 2011, Brain Research Bulletin.

[30]  W. Hou,et al.  The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo , 2010, Journal of Ethnopharmacology.

[31]  Hong Li,et al.  Emodin attenuates acute rejection of liver allografts by inhibiting hepatocellular apoptosis and modulating the Th1/Th2 balance in rats , 2010, Clinical and experimental pharmacology & physiology.

[32]  Dianqing Wu,et al.  GSK3: a multifaceted kinase in Wnt signaling. , 2010, Trends in biochemical sciences.

[33]  A. Weeraratna,et al.  Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt , 2009, Pigment cell & melanoma research.

[34]  Beibei Wu,et al.  Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. , 2007, Immunity.

[35]  S. Chu,et al.  Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. , 2006, Carcinogenesis.

[36]  Xiao-yan Chen,et al.  Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages. , 2005, International journal of molecular medicine.

[37]  Hiroshi Sato,et al.  Roles of membrane‐type matrix metalloproteinase‐1 in tumor invasion and metastasis , 2005, Cancer science.

[38]  A. Offidani,et al.  Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions , 2002, Cancer.

[39]  V. Kähäri,et al.  Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets , 2002, International journal of cancer.

[40]  D. Ruiter,et al.  Matrix metalloproteinases in human melanoma. , 2000, The Journal of investigative dermatology.

[41]  V. Lagente,et al.  Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[42]  M. Kallioinen,et al.  MATRIX METALLOPROTEINASE‐2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE , 1996, The Journal of pathology.

[43]  A. B. Tiku,et al.  Emodin and Its Role in Chronic Diseases. , 2016, Advances in experimental medicine and biology.

[44]  A. Armstrong,et al.  Melanoma: epidemiology, diagnosis, treatment, and outcomes. , 2012, Dermatologic clinics.

[45]  P. Ciborowski,et al.  Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: Potential role in metastasis , 2004, Clinical & Experimental Metastasis.